Distribution of somatostatin in pancreatic ductal adenocarcinoma remodels the normal pattern of the protein during foetal pancreatic development: An immunohistochemical analysis

Clinical and Experimental Medicine

Volumn 5, Issue 3, 2005, Pages 106-111

  Tamiolakis, D ^a   Simopoulos, C ^b   Venizelos, J ^b   Lambropoulou, M ^b   Nikolaidou, S ^a   Tsikouras, P ^b   Koutsougeras, G ^c   Alexiadis, G ^b   Menegaki, M ^b   Papadopoulos, N ^b  

^a Chania General Hospital St George   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c UNIVERSITY GENERAL HOSPITAL OF ALEXANDROUPOLIS   (Greece)

Author keywords

Foetal pancreatic tissue; Pancreatic carcinoma; Somatostatin

Indexed keywords

PROTEIN; SOMATOSTATIN;

ARTICLE; CANCER TISSUE; CELL DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; EMBRYO DEVELOPMENT; EPITHELIUM; FETUS; FETUS DEVELOPMENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NEOPLASM; PANCREAS; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS DUCT; PANCREAS ISLET; PRIMORDIUM; PRIORITY JOURNAL; TISSUE SECTION;

ADENOCARCINOMA; CARCINOMA, PANCREATIC DUCTAL; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; PANCREAS; PANCREATIC NEOPLASMS; SOMATOSTATIN;

EID: 27744484055     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-005-0073-4     Document Type: Article

References (25)

1. Le Douarin N (1982) The neural crest. Developmental and cell biology series. Cambridge University Press, Cambridge
2. Le Douarin N (1988) On the origin of pancreatic endocrine cells. Cell 53:169-171
3. Hahn von Dorsche H, Reiher H, Hahn H (1988) Phases in the early development of the human islet organ. Anat Anz 166:69-71
4. Like A, Orci L (1972) Embryogenesis of the human pancreatic islets: a light and electron microscopic study. Diabetes 21:511-534
5. Ferner H (1952) Das Inselsystem des Pancreas: Entwicklung, Histobiologie und Pathophysiologie mit besonderer Berucksichtigung des Diabetes mellitus. Thieme, Stuttgart
6. Benali N, Cordelier P, Calise D, Pages P, Rochaix P, Nagy A, Esteve J-P, Pour PM, Schally AV, Vaysse N, Susini C, Buscail L (2000) Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238. Proc Natl Acad Sci U.S.A. 97:9180-9185
7. Kloppel G, Heitz PU (1988) Pancreatic endocrine tumors. Pathol Res Pract 183:155-168
8. Ohashi O, Yamamoto M, Ishida H, Fujiwara H, Hasegawa Y, Saitoh Y (1997) The results of treatment for pancreatic cancer - statistic chance (in Japanese with English abstract). Nippon Geka Gakkai Zasshi [J Jpn Surg Soc] 98:588-591
9. Johnson LR (1981) Effects of gastrointestinal hormones on pancreatic growth. Cancer 47:1640-1645
10. Liebow C, Reilly C, Serrano M, Schally AV (1989) Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. Proc Natl Acad Sci U.S.A. 86:2003-2007
11. O'Byrne KJ, Scally AV, Thomas A, Carney DN, Steward WP (2001) Somatostatin, its receptors and analogs, in lung cancer. Chemotherapy 47[Suppl]:78-108
12. Wolff RA (2003) Chemoprevention for pancreatic cancer. Int J Gastrointest Cancer 33:27-41
13. Hofsli E (2002) The somatostatin receptor family - a window against new diagnosis and therapy of cancer. Tidsskr Nor Laegeforen 122:487-491
14. Vainas IG (2001) Octreotide in the management of hormone-refractory prostate cancer. Chemotherapy 47[Suppl]:109-126
15. Raderer M, Hamilton G, Kurtaran A, Valencak J, Haberl I, Hoffmann O, Kornek GV, Vorbeck F, Hejna MH, Virgolini I, Scheithauer W (1999) Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: in vitro and in vivo results. Br J Cancer 79:535-537
16. Qin RY, Fang RL, Gupta MK, Liu ZR, Wang DY, Chang Q, Chen YB (2004) Alteration of somatostatin receptor subtype 2 gene expression in pancreatic tumor angiogenesis. World J Gastroenterol 10:132-135
17. Reubi JC, Horisberger U, Essed CE, Jeekel J, Klijn JG, Lamberts SW (1988) Absence of somatostatin receptors in human exocrine pancreatic adenocarcinomas. Gastroenterology 95:760-763
18. Gupta MK, Qin RY (2003) Mechanism and its regulation of tumor-induced angiogenesis. World J Gastroenterol 9:1144-1155
19. Vernejoul F, Faure P, Benali N, Calise D, Tiraby G, Pradayrol L, Susini C, Buscail L (2002) Antitumor effect of in vivo somatostatin receptor subtype 2 gene transfer in primary and metastatic pancreatic cancer models. Cancer Res 62:6124-6131
20. Pollak MN, Scally AV (1998) Mechanisms of antineoplastic action of somatostatin analogs. Proc Soc Exp Biol Med 217:143-152
21. Buscail L, Vernejoul F, Faure P, Trrisani J, Susini C (2002) Regulation of cell proliferation by somatostatin. Ann Endocrinol 63:2513-2518
22. Bousquet C, Puente E, Buscail L, Vaysse N, Susini C (2001) Antiproliferative effect of somatostatin and analogs. Chemotherapy 47:30-39
23. Ferjoux G, Bouwquet C, Cordelier P, Benali N, Lopez F, Rochaix P, Buscail L, Susini C (2000) Signal transduction of somatostatin receptors negatively controlling cell proliferation. J Physiol Paris 94:205-210
24. Fisher WE, Wu Y, Amaya F, Berger DH (2002) Somatostatin receptor subtype 2 gene therapy inhibits pancreatic cancer in vitro. J Surg Res 105:58-64
25. Song SY (2004) Role of exocrine pancreatic progenitor cells in pancreatic carcinogenesis. Yonsei Med J 45 [Suppl]:74-75